Highly deplorable to overreact, entice fear without due diligence on COVID-19 vaccine: Vardhan
The health minister also referred to an earlier tweet by him on January 15, wherein he had posted a chart with details of all those people who should not get the vaccine.

The health minister also referred to an earlier tweet by him on January 15, wherein he had posted a chart with details of all those people who should not get the vaccine.
"Highly deplorable to over-react, entice fear and spread misinformation without performing an iota of due diligence. These facts have been in public domain since the beginning. Follow @MoHFW_INDIA (health ministry Twitter handel) to stay informed and do some research before speaking out," Vardhan tweeted.
In the factsheet on COVID-19 vaccine Covaxin, Bharat Biotech has advised pregnant or breastfeeding women and people with high fever or bleeding disorders not to take the antidote.
The vaccine maker in the fact sheet on Covaxin, posted in its website, said the clinical efficacy of the vaccine is yet to be established and is being studied in phase three clinical trial, and hence it is important to appreciate that receiving the vaccine does not mean other precautions related to COVID-19 need not be followed.
Covaxin has been granted approval for restricted use in emergency situations.
It is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.